Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Practice Study

World J Gastrointest Oncol. Jan 15, 2018; 10(1): 40-47
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.40

Table 1 Patient characteristics

Characteristic	n = 30
Sex, M/F	19/11
Age, median (range)	53 (30-70)
Tumor location, distance from anal verge
≤ 5 cm	19 (63)
> 5 cm	11 (37)
Clinical TN stage
T2N2	1 (3)
T3N0	2 (7)
T3N1	15 (50)
T3N2	12 (40)
Tumor differentiation
Well	10 (33)
Moderate	10 (33)
Poor	4 (14)
Mucinous	3 (10)
Signet ring cell	3 (10)

Unless otherwise stated, data are presented as n (%). M: Male; F: Female.

Citation: Gural Z, Saglam S, Yucel S, Kaytan-Saglam E, Asoglu O, Ordu C, Acun H, Sharifov R, Onder S, Kizir A, Oral EN. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study. World J Gastrointest Oncol 2018; 10(1): 40-47
URL: https://www.wjgnet.com/1948-5204/full/v10/i1/40.htm
DOI: https://dx.doi.org/10.4251/wjgo.v10.i1.40

Gural Z, Saglam S, Yucel S, Kaytan-Saglam E, Asoglu O, Ordu C, Acun H, Sharifov R, Onder S, Kizir A, Oral EN. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study. World J Gastrointest Oncol 2018; 10(1): 40-47 [PMID: 29375747 DOI: 10.4251/wjgo.v10.i1.40]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.